AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (711.9 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Anticancer effect of curcumin on breast cancer and stem cells

Hui-Tien LiuaYuan-Soon Hoa,b( )
Graduate Institute of Medical Sciences, College of Mediine, Taipei Medical University, Taipei, Taiwan, China
Graduate Institute of Medical Sciences, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan, China

Peer review under responsibility of KeAi Communications Co., Ltd.

Show Author Information

Abstract

Numerous studies have shown that curcumin, a natural compound, exerts anticancer effects by inhibiting cancer cell proliferation and metastasis and by inducing cell cycle arrest and apoptosis. In particular, curcumin exhibits potent inhibitory effects on breast cancer, the most prevalent type of cancer among women worldwide. It has low maximal inhibitory concentration for breast cancer cell lines that express the hormone receptor ER and sensitizes cell lines to anticancer drugs. Moreover, it can induce apoptosis in cell lines independently of hormone receptor expression. In addition, curcumin inhibits the proliferation of breast cancer stem cells (BCSC), an important factor that influences cancer recurrence. The inhibition of BCSC proliferation suppresses metastasis and reattachment, ultimately limiting tumor formation. A xenograft study similarly showed that curcumin exerts tumor-suppression effects on cancer cells and cancer stem cells. Therefore, curcumin is a potential anticancer compound, and its concurrent application with other anticancer drugs appears promising.

References

[1]

D.R. Siwak, S. Shishodia, B.B. Aggarwal, et al., Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway, Cancer 104 (4) (2005) 879-890.

[2]

K.M. Ruocco, E.I. Goncharova, M.R. Young, et al., A high-throughput cell-based assay to identify specific inhibitors of transcription factor AP-1, J. Biomol. Screen. 12 (1) (2007) 133-139.

[3]

S. Liu, Z. Wang, Z. Hu, et al., Anti-tumor activity of curcumin against androgen-independent prostate cancer cells via inhibition of NF-kappaB and AP-1 pathway in vitro, J. Huazhong Univ. Sci. Technol. Med. Sci. 31 (4) (2011) 530-534.

[4]

A. Chen, J. Xu, A.C. Johnson, Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1, Oncogene 25 (2) (2006) 278-287.

[5]

Q.Y. Chen, D.M. Jiao, L.F. Wang, et al., Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1, Mol. Biosyst. 11 (3) (2015) 859-868.

[6]

H.Y. Choi, J.E. Lim, J.H. Hong, Curcumin interrupts the interaction between the androgen receptor and Wnt/beta-catenin signaling pathway in LNCaP prostate cancer cells, Prostate Cancer Prostatic Dis. 13 (4) (2010) 343-349.

[7]

M. He, Y. Li, L. Zhang, et al., Curcumin suppresses cell proliferation through inhibition of the Wnt/beta-catenin signaling pathway in medulloblastoma, Oncol. Rep. 32 (1) (2014) 173-180.

[8]

S. Aggarwal, H. Ichikawa, Y. Takada, et al., Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation, Mol. Pharmacol. 69 (1) (2006) 195-206.

[9]

P.H. Killian, E. Kronski, K.M. Michalik, et al., Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2, Carcinogenesis 33 (12) (2012) 2507-2519.

[10]

H. Zong, F. Wang, Q.X. Fan, et al., Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways, Mol. Biol. Rep. 39 (4) (2012) 4803-4808.

[11]

J. Ravindran, S. Prasad, B.B. Aggarwal, Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?, AAPS J. 11 (3) (2009) 495-510.

[12]

C.L. Yang, Y.Y. Liu, Y.G. Ma, et al., Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway, PLoS One 7 (5) (2012) e37960.

[13]

T.G. Lim, S.Y. Lee, Z. Huang, et al., Curcumin suppresses proliferation of colon cancer cells by targeting CDK2, Cancer Prev. Res. (Phila.) 7 (4) (2014) 466-474.

[14]

M.A. Khan, S. Gahlot, S. Majumdar, Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets, Mol. Cancer Ther. 11 (9) (2012) 1873-1883.

[15]

F. Song, L. Zhang, H.X. Yu, et al., The mechanism underlying proliferation-inhibitory and apoptosis-inducing effects of curcumin on papillary thyroid cancer cells, Food Chem. 132 (1) (2012) 43-50.

[16]

G. Kaushik, T. Kaushik, S.K. Yadav, et al., Curcumin sensitizes lung adenocarcinoma cells to apoptosis via intracellular redox status mediated pathway, Indian J. Exp. Biol. 50 (12) (2012) 853-861.

[17]

C.C. Su, J.G. Lin, T.M. Li, et al., Curcumin-induced apoptosis of human colon cancer colo 205 cells through the production of ROS, Ca2+ and the activation of caspase-3, Anticancer Res. 26 (6B) (2006) 4379-4389.

[18]

T.W. Tan, H.R. Tsai, H.F. Lu, et al., Curcumin-induced cell cycle arrest and apoptosis in human acute promyelocytic leukemia HL-60 cells via MMP changes and caspase-3 activation, Anticancer Res. 26 (6B) (2006) 4361-4371.

[19]

A. Ibrahim, A. El-Meligy, G. Lungu, et al., Curcumin induces apoptosis in a murine mammary gland adenocarcinoma cell line through the mitochondrial pathway, Eur. J. Pharmacol. 668 (1–2) (2011) 127-132.

[20]

D.E. Gomez, R.G. Armando, H.G. Farina, et al., Telomere structure and telomerase in health and disease (review), Int. J. Oncol. 41 (5) (2012) 1561-1569.

[21]

S. Chakraborty, U. Ghosh, N.P. Bhattacharyya, et al., Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells, Mutat. Res. 596 (1–2) (2006) 81-90.

[22]

S. Mukherjee Nee Chakraborty, U. Ghosh, N.P. Bhattacharyya, et al., Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity, Mol. Cell. Biochem. 297 (1–2) (2007) 31-39.

[23]

A.K. Khaw, M.P. Hande, G. Kalthur, et al., Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells, J. Cell. Biochem. 114 (6) (2013) 1257-1270.

[24]

T. Sorlie, C.M. Perou, R. Tibshirani, et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. U. S. A. 98 (19) (2001) 10869-10874.

[25]

J.S. Parker, M. Mullins, M.C. Cheang, et al., Supervised risk predictor of breast cancer based on intrinsic subtypes, J. Clin. Oncol. 27 (8) (2009) 1160-1167.

[26]

H.W. Lai, S.Y. Chien, S.J. Kuo, et al., The potential utility of curcumin in the treatment of HER-2-overexpressed breast cancer: an in vitro and in vivo comparison study with herceptin, Evid Based Complement. Altern. Med. 2012 (2012) 486568.

[27]

S.P. Verma, E. Salamone, B. Goldin, Curcumin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogenic pesticides, Biochem. Biophys. Res. Commun. 233 (3) (1997) 692-696.

[28]

D. Karunagaran, R. Rashmi, T.R. Kumar, Induction of apoptosis by curcumin and its implications for cancer therapy, Curr. Cancer Drug Targets 5 (2) (2005) 117-129.

[29]

D.L. Rowe, T. Ozbay, R.M. O’Regan, et al., Modulation of the BRCA1 protein and induction of apoptosis in triple negative breast cancer cell lines by the polyphenolic compound curcumin, Breast Cancer (Auckl.) 3 (2009) 61-75.

[30]

Z.M. Shao, Z.Z. Shen, C.H. Liu, et al., Curcumin exerts multiple suppressive effects on human breast carcinoma cells, Int. J. Cancer 98 (2) (2002) 234-240.

[31]

Q. Zhou, M. Ye, Y. Lu, et al., Curcumin improves the tumoricidal effect of mitomycin C by suppressing ABCG2 expression in stem cell-like breast cancer cells, PLoS One 10 (8) (2015) e0136694.

[32]

Q.M. Zhou, Y. Sun, Y.Y. Lu, et al., Curcumin reduces mitomycin C resistance in breast cancer stem cells by regulating Bcl-2 family-mediated apoptosis, Cancer Cell Int. 17 (2017) 84.

[33]

S. Mukherjee, M. Mazumdar, S. Chakraborty, et al., Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/beta-catenin negative feedback loop, Stem Cell Res. Ther. 5 (5) (2014) 116.

[34]

M.S. Charpentier, R.A. Whipple, M.I. Vitolo, et al., Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment, Cancer Res. 74 (4) (2014) 1250-1260.

[35]

W. Chen, L. Li, X. Zhang, et al., Curcumin: a calixarene derivative micelle potentiates anti-breast cancer stem cells effects in xenografted, triple-negative breast cancer mouse models, Drug Deliv. 24 (1) (2017) 1470-1481.

Food Science and Human Wellness
Pages 134-137
Cite this article:
Liu H-T, Ho Y-S. Anticancer effect of curcumin on breast cancer and stem cells. Food Science and Human Wellness, 2018, 7(2): 134-137. https://doi.org/10.1016/j.fshw.2018.06.001

443

Views

14

Downloads

98

Crossref

N/A

Web of Science

108

Scopus

0

CSCD

Altmetrics

Received: 30 April 2018
Accepted: 06 June 2018
Published: 09 June 2018
© 2018 “Society information”.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return